Clinical Research Directory
Browse clinical research sites, groups, and studies.
68Ga-NYM096 PET/CT in Various Kinds of Cancer
Sponsor: Peking Union Medical College Hospital
Summary
This is a prospective, single-center study aimed at evaluating the uptake characteristics of 68Ga-NYM096 PET/CT in various kinds of tumors including primary and metastatic lesions. Based on image analysis, this study will assess the uptake of various kinds of tumors using 68Ga-NYM096 PET/CT. The findings will provide critical insights into the tumor uptake on 68Ga-NYM096 PET/CT to identify the most promising indications for future application.
Official title: 68Ga-NYM096 PET/CT: Tracer Uptake in Various Kinds of Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2025-08-01
Completion Date
2027-10-01
Last Updated
2025-09-05
Healthy Volunteers
No
Conditions
Interventions
68Ga-NYM096 PET/CT
Participants will be administered a single, intravenous bolus of 68Ga-NYM096 The recommended administered activity of 68Ga-NYM096 is 1.8-2.2 MBq per kilogram bodyweight, subject to variation that may be required owing to variable elution efficiencies obtained during the lifetime of the 68Ga / 68Ga generator. The CT and PET imaging session will begin approximately 45 to 75 minutes after 68Ga-NYM096 administration.
Locations (1)
Peking Union Medical College Hospital, Beijing, Beijing 100730
Beijing, China